Immunocore Holdings Plc (NASDAQ:IMCR) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Last week, you might have seen that Immunocore Holdings plc (NASDAQ:IMCR) released its quarterly result to the market. The early response was not positive, with shares down 2.1% to US$58.95 in the pas

Simply Wall StMay 11 20:01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Immunocore Holdings (IMCR), Warby Parker (WRBY) and Ocular Therapeutix (OCUL)

TipRanksMay 10 13:41

Analysts Offer Insights on Healthcare Companies: Tango Therapeutics (TNGX), Aclaris Therapeutics (ACRS) and Immunocore Holdings (IMCR)

TipRanksMay 10 13:30

Immunocore Holdings Price Target Raised to $67.00/Share From $63.00 by Canaccord Genuity

Immunocore Holdings Price Target Raised to $67.00/Share From $63.00 by Canaccord Genuity

Dow JonesMay 10 03:03

Immunocore Holdings Is Maintained at Buy by HC Wainwright & Co.

Immunocore Holdings Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMay 10 01:59

HC Wainwright & Co. : Maintaining the Immunocore Hldgs (IMCR.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $90.00 to $100.00.

HC Wainwright & Co. : Maintaining the Immunocore Hldgs (IMCR.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $90.00 to $100.00.

Zhitong FinanceMay 10 01:50